Shuko Harada

Dr. Shuko Harada


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
SHShuko Harada
Shuko Harada
ACAnna Caliò
Anna Caliò
KJKaren M. Janowski
Karen M. Janowski
DMDiana Morlote
Diana Morlote
MPMaria D. Rodriguez Pena
Maria D. Rodriguez Pena
AMAlexander Craig Mackinnon
Alexander Craig Mackinnon

20 March 2019 in American Journal of Clinical Pathology
Verified
Journal Article
Closed access
DMDiana Morlote
Diana Morlote
KJKaren M Janowski
Karen M Janowski
RSRance C Siniard
Rance C Siniard
RGRong Jun Guo
Rong Jun Guo
TWThomas Winokur
Thomas Winokur
SHShuko Harada
Shuko Harada
To compare the effects of two methods of formalin-fixed paraffin-embedded (FFPE) tissue harvesting on DNA quality and next-generation sequencing (NGS) quality metrics. DNA integrity number (DIN) and NGS quality metrics resulting from DNA extraction and sequencing of 199 sequential samples harvested via the Pinpoint Slide DNA Isolation System and the punch method were compared. DNA extracted from FFPE tissue punches had higher DIN than that extracted from Pinpoint samples (mean ± SD, 6.18 ± 0.83 vs 5.09 ± 0.91; P < .0001), indicating less degradation. Lower DIN correlated with lower-quality metrics of NGS, that is lower percentage of unique on-target reads, average depth of coverage, and percentage of positions with coverage depth greater than or equal to 100×, 400×, and 1,000×. Our study demonstrated methods to harvest tissue from FFPE blocks may affect quality of DNA, which in turn has an effect on other NGS quality metrics.

1 June 2008 in Annals of Diagnostic Pathology
Verified
Journal Article
Closed access
SHShuko Harada
Shuko Harada
HKHari Kalla
Hari Kalla
MBManjula Balasubramanian
Manjula Balasubramanian
IBIsadore Brodsky
Isadore Brodsky
DGDouglas Gladstone
Douglas Gladstone
JHJ. Steve Hou
J. Steve Hou

25 January 2017 in Genes, Chromosomes and Cancer
Verified
Journal Article
Closed access
PDF file
NJNatini Jinawath
Natini Jinawath
MSMeng‐Shin Shiao
Meng‐Shin Shiao
ANAlexis Norris
Alexis Norris
KMKathleen Murphy
Kathleen Murphy
AKAlison P. Klein
Alison P. Klein
SHShuko Harada
Shuko Harada

11 June 2020 in American Journal of Clinical Pathology
Verified
Journal Article
Open access
PDF file
GTGregory Tsongalis
Gregory Tsongalis
MTM Rabie Al Turkmani
M Rabie Al Turkmani
MSMichael Suriawinata
Michael Suriawinata
MBMichael J Babcock
Michael J Babcock
KMKristi Mitchell
Kristi Mitchell
KPKashyap Patel
Kashyap Patel
Objectives: Management of colorectal cancer warrants mutational analysis of KRAS/NRAS when considering anti–epidermal growth factor receptor therapy and BRAF testing for prognostic stratification. In this multicenter study, we compared a fully integrated, cartridge-based system to standard-of-care assays used by participating laboratories. Methods: Twenty laboratories enrolled 874 colorectal cancer cases between November 2017 and December 2018. Testing was performed on the Idylla automated system (Biocartis) using the KRAS and NRAS-BRAF cartridges (research use only) and results compared with in-house standard-of-care testing methods. Results: There were sufficient data on 780 cases to measure turnaround time compared with standard assays. In-house polymerase chain reaction (PCR) had an average testing turnaround time of 5.6 days, send-out PCR of 22.5 days, in-house Sanger sequencing of 14.7 days, send-out Sanger of 17.8 days, in-house next-generation sequencing (NGS) of 12.5 days, and send-out NGS of 20.0 days. Standard testing had an average turnaround time of 11 days. Idylla average time to results was 4.9 days with a range of 0.4 to 13.5 days. Conclusions: The described cartridge-based system offers rapid and reliable testing of clinically actionable mutation in colorectal cancer specimens directly from formalin-fixed, paraffin-embedded tissue sections. Its simplicity and ease of use compared with other molecular techniques make it suitable for routine clinical laboratory testing.

20 May 2017 in Virchows Archiv
Verified
Journal Article
Closed access
PDF file
RSRance C. Siniard
Rance C. Siniard
SHShuko Harada
Shuko Harada